China Nuokang Bio-Pharmaceutical Inc.

Delisted

CIK 1474952fmd_0EVBZ6WCFP5MA80QP2668SQXJ5Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Dec 31, 2011, 3 periods

Income Statement · Annual · Millions · CNY
Line item	FY2009	FY2010	FY2011
Total revenues	283	316	288
Cost of revenue	36	37	38
Gross profit	247	278	250
Research and development	8	14	16
Selling, general and administrative	158	199	215
Total operating expenses	166	213	231
Operating income	81	66	19
Interest expense	3	7	3
Interest and investment income	1	1	2
Other non-operating income (expense)	3	2	(13)
Income before taxes	82	57	(1)
Income tax expense	17	11	13
Net income from continuing operations	65	46	(14)
Net income	65	46	(14)
Net income to common shareholders	51	46	(14)